Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

被引：36

作者：

Dong, Caixia ^{[1
,2
]}

Ding, Yuwei ^{[1
,2
,3
]}

Weng, Shanshan ^{[1
,2
]}

Li, Guichao ^{[4
]}

Huang, Yanqing ^{[2
,3
]}

Hu, Hanguang ^{[1
,2
,3
]}

Zhang, Zhen ^{[4
]}

Zhang, Suzhan ^{[2
,3
,5
]}

Yuan, Ying ^{[1
,2
,3
]}

机构：

[1] Zhejiang Univ, Dept Med Oncol, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Peoples R China

[2] Zhejiang Univ, Canc Ctr, Hangzhou 310058, Zhejiang, Peoples R China

[3] Zhejiang Univ, Canc Inst, Key Lab Canc Prevent & Intervent, Minist Educ,Affiliated Hosp 2,Sch Med, Hangzhou 310009, Peoples R China

[4] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Hosp, Shanghai 200032, Peoples R China

[5] Zhejiang Univ, Dept Colorectal Surg, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Peoples R China

来源：

CHINESE JOURNAL OF CANCER RESEARCH | 2021年 / 33卷 / 03期

基金：

中国国家自然科学基金; 国家重点研发计划;

关键词：

OPEN-LABEL; MULTICENTER; BEVACIZUMAB; TAS-102;

D O I：

10.21147/j.issn.1000-9604.2021.03.02

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：302 / 307

页数：6

共 21 条

[1] Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer [J].

Andre, T. ;

Shiu, K-K ;

Kim, T. W. ;

Jensen, B., V ;

Jensen, L. H. ;

Punt, C. ;

Smith, D. ;

Garcia-Carbonero, R. ;

Benavides, M. ;

Gibbs, P. ;

de la Fouchardiere, C. ;

Rivera, F. ;

Elez, E. ;

Bendell, J. ;

Le, D. T. ;

Yoshino, T. ;

Van Cutsem, E. ;

Yang, P. ;

Farooqui, M. Z. H. ;

Marinello, P. ;

Diaz, L. A., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2207-2218

[2] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial [J].

Bahadoer, Renu R. ;

Dijkstra, Esmee A. ;

van Etten, Boudewijn ;

Marijnen, Corrie A. M. ;

Putter, Hein ;

Kranenbarg, Elma Meershoek-Klein ;

Roodvoets, Annet G. H. ;

Nagtegaal, Iris D. ;

Beets-Tan, Regina G. H. ;

Blomqvist, Lennart K. ;

Fokstuen, Tone ;

ten Tije, Albert J. ;

Capdevila, Jaume ;

Hendriks, Mathijs P. ;

Edhemovic, Ibrahim ;

Cervantes, Andres ;

Nilsson, Per J. ;

Glimelius, Bengt ;

van de Velde, Cornelis J. H. ;

Hospers, Geke A. P. .

LANCET ONCOLOGY, 2021, 22 (01) :29-42

[3] Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial [J].

Cremolini, Chiara ;

Rossini, Daniele ;

Dell'Aquila, Emanuela ;

Lonardi, Sara ;

Conca, Elena ;

Del Re, Marzia ;

Busico, Adele ;

Pietrantonio, Filippo ;

Danesi, Romano ;

Aprile, Giuseppe ;

Tamburini, Emiliano ;

Barone, Carlo ;

Masi, Gianluca ;

Pantano, Francesco ;

Pucci, Francesca ;

Corsi, Domenico C. ;

Pella, Nicoletta ;

Bergamo, Francesca ;

Rofi, Eleonora ;

Barbara, Cecilia ;

Falcone, Alfredo ;

Santini, Daniele .

JAMA ONCOLOGY, 2019, 5 (03) :343-350

[4] Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer A Randomized Phase 2 Clinical Trial [J].

Cremolini, Chiara ;

Antoniotti, Carlotta ;

Lonardi, Sara ;

Aprile, Giuseppe ;

Bergamo, Francesca ;

Masi, Gianluca ;

Grande, Roberta ;

Tonini, Giuseppe ;

Mescoli, Claudia ;

Cardellino, Giovanni Gerardo ;

Coltelli, Luigi ;

Salvatore, Lisa ;

Corsi, Domenico Cristiano ;

Lupi, Cristiana ;

Gemma, Donatello ;

Ronzoni, Monica ;

Dell'Aquila, Emanuela ;

Marmorino, Federica ;

Di Fabio, Francesca ;

Mancini, Maria Laura ;

Marcucci, Lorenzo ;

Fontanini, Gabriella ;

Zagonel, Vittorina ;

Boni, Luca ;

Falcone, Alfredo .

JAMA ONCOLOGY, 2018, 4 (04) :529-536

[5] Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 [J].

Zhang, Suzhan ;

Li, Jin ;

Cai, Sanjun ;

Chen, Gong ;

Cai, Muyan ;

Chen, Gong ;

Gao, Yuanhong ;

Lai, Maode ;

Li, Guichao ;

Li, Xinxiang ;

Liang, Houjie ;

Nan, Kejun ;

Ren, Li ;

Sheng, Weiqi ;

Wang, Yi ;

Wang, Xicheng ;

Xu, Jianmin ;

Xu, Ruihua ;

Yuan, Ying ;

Zhang, Zhen ;

Zhou, Aiping .

CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (01) :117-134

[6] Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial [J].

Garcia-Aguilar, Julio ;

Chow, Oliver S. ;

Smith, David D. ;

Marcet, Jorge E. ;

Cataldo, Peter A. ;

Varma, Madhulika G. ;

Kumar, Anjali S. ;

Oommen, Samuel ;

Coutsoftides, Theodore ;

Hunt, Steven R. ;

Stamos, Michael J. ;

Ternent, Charles A. ;

Herzig, Daniel O. ;

Fichera, Alessandro ;

Polite, Blase N. ;

Dietz, David W. ;

Patil, Sujata ;

Avila, Karin .

LANCET ONCOLOGY, 2015, 16 (08) :957-966

[7] ModifiedFOLFOXIRIWith or Without Cetuximab as Conversion Therapy in Patients withRAS/BRAFWild-TypeUnresectable Liver Metastases Colorectal Cancer: TheFOCULMMulticenter PhaseIITrial [J].

Hu, Huabin ;

Wang, Kun ;

Huang, Meijin ;

Kang, Liang ;

Wang, Wei ;

Wang, Hui ;

Qiu, Meng ;

Lin, Rongbo ;

Zhang, Haibo ;

Lan, Ping ;

Wu, Xiaojian ;

Liu, Guangjian ;

Wan, Yunle ;

Liu, Ming ;

Zhou, Zhiyang ;

Huang, Yan ;

Li, Fangqian ;

Zhang, Jianwei ;

Cai, Yue ;

Ma, Tenghui ;

Zhou, Jiaming ;

Wang, Huaiming ;

Ling, Jiayu ;

Cai, Yonghua ;

Wu, Zehua ;

Luo, Shuangling ;

Ling, Li ;

Deng, Yanhong .

ONCOLOGIST, 2021, 26 (01) :E90-E98

[8]

Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI [10.1056/NEJMoa1311194, 10.1056/NEJMc1405215]

[9]

Kopetz S, 2020, J CLIN ONCOL, V38

[10] TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study [J].

Kuboki, Yasutoshi ;

Nishina, Tomohiro ;

Shinozaki, Eiji ;

Yamazaki, Kentaro ;

Shitara, Kohei ;

Okamoto, Wataru ;

Kajiwara, Takeshi ;

Matsumoto, Toshihiko ;

Tsushima, Takahiro ;

Mochizuki, Nobuo ;

Nomura, Shogo ;

Doi, Toshihiko ;

Sato, Akihiro ;

Ohtsu, Atsushi ;

Yoshino, Takayuki .

LANCET ONCOLOGY, 2017, 18 (09) :1172-1181

← 1 2 3 →